Clinical trial
Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the…
NCT00010166 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00010166 |
|---|---|
| Title | Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas |
| Official title | Phase II Trial Of Adjuvant 2'2'-Difluoro-2'-Deoxycytidine (Gemcitabine) And External Beam Radiation For The Treatment Of Resectable Pancreatic Cancer |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | gemcitabine hydrochloride, adjuvant therapy, radiation therapy |
| Enrollment | 26 |
| Start date | Dec 1, 2000 |
| Primary completion | Oct 3, 2003 |
| Completion | Oct 3, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 9, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: